CAMBRIDGE ALLERGY LTD

Active Gosport

Research and experimental development on biotechnology

11 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
C

CAMBRIDGE ALLERGY LTD

Research and experimental development on biotechnology

Founded 7 Dec 2015 Active Gosport, England 11 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 5 Jun 2025 Next due 30 Sept 2026 5 months remaining
Confirmation Submitted 20 Dec 2025 Next due 20 Dec 2026 7 months remaining
Net assets £284K £292K 2024 year on year
Total assets £660K £198K 2024 year on year
Total Liabilities £376K £94K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Hoeford Point Barwell Lane Gosport Hampshire PO13 0AU England

Email

info@example.com

Website

www.example.com

Full company profile for CAMBRIDGE ALLERGY LTD (09905065), an active life sciences and medical technology company based in Gosport, England. Incorporated 7 Dec 2015. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2016–2024)

Cash in Bank

£110.50k

Decreased by £68.91k (-38%)

Net Assets

£284.09k

Decreased by £291.75k (-51%)

Total Liabilities

£375.60k

Increased by £93.66k (+33%)

Turnover

N/A

Employees

11

Decreased by 3 (-21%)

Debt Ratio

57%

Increased by 24 (+73%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 2
Grants 3

Investors (3)

Investor NameInvestor SinceParticipating Rounds
Investor 1Dec 2017Seed
Investor 2Dec 2017Seed
Investor 4Dec 2023Crowdfunding

Share Capital

Share Capital

Share allotments and capital structure

28 Allotments 1,779,826 Shares £5.73m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
1 Sept 20252,066£0.207£0
4 Jul 2025686,554£473k£0.689
16 May 2025105,300£58k£0.551
16 May 20252,745£2k£0.689
7 Jan 202532,954£193k£5.85

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (38)

Cambridge University Hospitals Nhs Foundation Trust
19.7%
653,007
Syndicate Room Nominees Ltd
11.6%
384,092

Persons with Significant Control

Persons with Significant Control (0)

0 Active 2 Ceased

Jonathan Simon Milner

Ceased 4 Jul 2023

Ceased

Group Structure

Group Structure

CAMBRIDGE ALLERGY LTD Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
20 Dec 2025Confirmation StatementConfirmation statement made on 2025-12-06 with updates
20 Dec 2025OfficersChange to director Mr Edward Smith on 2025-05-16
18 Dec 2025OfficersAppointment of Mr David Allan Newble as director on 2025-12-01
15 Sept 2025OfficersAppointment of Dr Andrew Thomas Clark as director
12 Sept 2025CapitalAllotment of shares (GBP 331.861) on 2025-09-01
20 Dec 2025 Confirmation Statement

Confirmation statement made on 2025-12-06 with updates

20 Dec 2025 Officers

Change to director Mr Edward Smith on 2025-05-16

18 Dec 2025 Officers

Appointment of Mr David Allan Newble as director on 2025-12-01

15 Sept 2025 Officers

Appointment of Dr Andrew Thomas Clark as director

12 Sept 2025 Capital

Allotment of shares (GBP 331.861) on 2025-09-01

Recent Activity

Latest Activity

Confirmation statement made on 2025-12-06 with updates

4 months ago on 20 Dec 2025

Change to director Mr Edward Smith on 2025-05-16

4 months ago on 20 Dec 2025

Appointment of Mr David Allan Newble as director on 2025-12-01

4 months ago on 18 Dec 2025

Appointment of Dr Andrew Thomas Clark as director

7 months ago on 15 Sept 2025

Allotment of shares (GBP 331.861) on 2025-09-01

7 months ago on 12 Sept 2025